WHO, “Alcohol and Mental Health,” World Health Organization, Regional Office for Europe, WHO European Ministerial Conference on Mental Health, Helsinki, 12-15 January 2005; Helsinki Conference Secretariat, Copenhagen, 2005.
 J. Mbatia, R. Jenkins, N. Singleton and B. White, “Prevalence of Alcohol Consumption and Hazardous Drinking, Tobacco and Drug Use in Urban Tanzania, and Their Associated Risk Factors,” International Journal of Environmental Research and Public Health, Vol. 6, No. 7, 2009, pp. 1992-2003.
 WHO-UNAIDS, “Global Adults and Children Estimated to Be Living with HIV in 2012 Report,” World Health Organization, UNAIDS, 2012.
 UMoH, “Uganda AIDS Indicator Survey Report 2011,” Uganda Ministry of Health (UMoH), 2011.
 A. Kafuko and P. Bukuluki, “Qualitative Research in Uganda on Knowledge, Attitude and Practices Concerning Alcohol, 2008,” USAID, Health Communication, YEAH and Afford: Corporate Agreement Number 617-A00-07-00005-00, 2008.
 B. Neild, “Uganda Leads Its African Neighbors for Alcohol Intake: World’s 10 Best Drinking Nations,” Cable News Network (CNN) Report, 2013.
 WHO/UNICEF/UNAIDS, “Global HIV/AIDS Response: Epidemic Update and Health Sector Progress towards Universal Access, Progress Report 2011-2015,” World Health Organization HIV/AIDS Department, Geneva, 2011.
 M. Y. Eng, S. E. Luczak and T. L. Wall, “ALDH2, ADH1B and ADH1C Genotypes in Asians: A Literature Review,” The Journal of the National Institute on Alcohol Abuse and Alcoholism, Vol. 30, No. 1, 2007, pp. 22-26.
 D. M. Scott and R. E. Taylor, “Health-Related Effects of Genetic Variations of Alcohol-Metabolizing Enzymes in African Americans,” The Journal of the National Institute on Alcohol Abuse and Alcoholism, Vol. 30, No. 1, 2007, pp. 18-20.
 K. S. Salmela, I. G. Kessova, I. B. Tsyrlov and C. S. Lieber, “Respective Roles of Human Cytochrome P-4502E1, 1A2 and 3A4 in the Hepatic Microsomal Ethanol Oxidizing System,” Alcoholism: Clinical and Experimental Research, Vol. 22, No. 9, 1998, pp. 2125-2132.
 C. S. Lieber, “Relationships between Nutrition, Alcohol Use, and Liver Disease,” National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2004.
 M. L. Ojeda, B. Vázquez, F. Nogales, M. Murillo and O. Carreras, “Ethanol Consumption by Wistar Rat Dams Affects Selenium Bioavailability and Antioxidant Balance in Their Progeny,” International Journal of Environmental Research and Public Health, Vol. 6, No. 8, 2009, pp. 2139-2149. http://dx.doi.org/10.3390/ijerph6082139
 S. Kubota, N. Amino, Y. Matsumoto, N. Ikeda, S. Morita, T. Kudo, H. Ohye, E. Nishihara, M. Ito, S. Fukata and A. Miyauchi, “Serial Changes in Liver Function Tests in Patients with Thyrotoxicosis Induced by Graves’ Disease and Painless Thyroiditis,” Thyroid, Vol. 18, No. 3, 2008, pp. 283-287. http://dx.doi.org/10.1089/thy.2007.0189
 E. W. Tiemersma, P. A. Wark, M. C. Ocke, A. Bunschoten, M. H. Otten, F. J. Kok and E. Kampman, “Alcohol Consumption, Alcohol Dehydrogenase 3 Polymorphism, and Colorectal Adenomas,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 12, No. 5, 2003, pp. 419-425.
 C. P. Wild and R. Montesano, “A Model of Interaction: Aflatoxins and Hepatitis Viruses in Liver Cancer Aetiology and Prevention,” Cancer Letters, Vol. 286, No. 1, 2009, pp. 22-28.
 M. C. Braude and H. M. Chao, “Genetic and Biological Markers in Drug Abuse and Alcoholism,” National Institute on Drug Abuse (NIDA) Research Monograph 66 1986. Department of Health and Human Service. Alcohol, Drug Abuse, and Mental Health Administration. Maryland, 1996, pp. 1-50.
 K. M. Conigrave, L. J. Degenhardt, J. B. Whitfield, J. B. Saunders, A. Helander and B. Tabakoff, “CDT, GGT, and AST as Markers of Alcohol Use: The WHO/ISBRA Collaborative Project,” Alcoholism: Clinical and Experimental Research, Vol. 26, No. 3, 2002, pp. 332-338.
 A. Helander, B. Tabakoff and WHO/ISBRA Study Centers, “Biochemical Markers of Alcohol Use and Abuse: Experience from the Pilot Study of the WHO/ISBRA Collaborative Project on State and Trait Markers of Alcohol,” Alcohol & Alcoholism, Vol. 32, No. 2, 1997, pp. 133-144.
 Y. Littner and C. F. Bearer, “Detection of Alcohol Consumption during Pregnancy—Current and Future Biomarkers,” Elsevier publishers, Neuroscience and Biobehavioral Reviews, Vol. 31, No. 2, 2007, pp. 261-269.
 T. F. Babor, J. C. Higgins-Biddle, J. B. Saunders and M. G. Monteiro, “The Alcohol Use Disorders Identification Test (AUDIT) Manual: Guidelines for Use in Primary Care,” 2nd Edition, Department of Mental Health and Substance Dependence, World Health Organization, 2001, pp. 4-32.
 L. L. Brunton, J. S. Lazo and K. L. Parker, “Antiretroviral Agents and Treatment of HIV Infection,” Goodman and Gilman’s the Pharmacological Basis of Therapeutics, 11th Edition, McGraw-Hill, New York, 2006, pp. 1273-1309.
 G. Gómez-Moreno, J. Guardia, A. Cutando and J. Calvo-Guirado, “Pharmacological Interactions of Anti-Microbial Agents in Odontology,” Medicina Oral, Patología Oral y Cirugía Bucal, Vol. 14, No. 3, 2009, pp. E123-E128.
 S. K. Das, P. Nayak and D. M. Vasudevan, “Biochemical Markers for Alcohol Consumption,” Indian Journal of Clinical Biochemistry, Vol. 18, No. 2, 2003, pp. 111-118.